US 8697666
Anti-cancer oligodeoxynucleotides
granted A61KA61K31/7088A61P
Quick answer
US patent 8697666 (Anti-cancer oligodeoxynucleotides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61P, A61P35/00